Fredrik Borgsten

Daratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease res...

Bortezomib, melphalan, and prednisone with or without daratumumab in transplant-ineligible patiënten met newly diagno...